Portfolia

Investor type Venture Capital
Founders Trish Costello

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 80
Average round size
info
The average size of a deal this fund participated in
$4M
Portfolio companies 58
Rounds per year 10.00
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.28
Exits 4
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Health Care
  • Software
  • Medical Device
  • Biotechnology
  • Internet
Summary

Portfolia is the famous Corporate Investor, which was founded in 2012. The main office of represented Corporate Investor is situated in the Menlo Park. The company was established in North America in United States.

The high activity for fund was in 2018. The fund is generally included in 2-6 deals every year. The common things for fund are deals in the range of 5 - 10 millions dollars. When the investment is from Portfolia the average startup value is 50-100 millions dollars. This Portfolia works on 23 percentage points less the average amount of lead investments comparing to the other organizations.

The current fund was established by Trish Costello.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Portfolia, startups are often financed by GoBeyond, Astia Angels, Sand Hill Angels. The meaningful sponsors for the fund in investment in the same round are Astia Angels, iNovia Capital, Zelkova Ventures. In the next rounds fund is usually obtained by Uncork Capital, Golden Seeds, GoBeyond.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Personal Health, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Voxeet, Madorra, Envoy - helloenvoy.com The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Portfolia:
Typical Co-investors
Portfolia is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Portfolia:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
All American Properties -
Biodiscovery V -
Bow Wave Capital Management New York, New York, United States
Digital Health Ventures Berlin, Berlin, Germany
Dinglong Culture China, Guangdong Province, Shantou
Elastica California, Mountain View, United States
Hua Hsia Investment Holding Co Taipei, Taiwan
Intercorp Financial Services Lima, Lima, Peru
LMK Ventures -
Making Ideas Business Community of Madrid, Madrid, Spain
OPKO Health Florida, Miami, United States
Pioneers Ventures Austria, Linz, Oberosterreich
PoliHub Italy, Lombardia, Milano
Presbyterian Healthcare Services Clovis, New Mexico, United States
Reshape New York, New York, United States
Ridgeline Partners California, San Francisco, United States
Weijia Investment China, Ningbo, Zhejiang
Witruth Capital Beijing, Beijing, China
Wolf Family Trust Massachusetts, United States, Wayland
Zhejiang Meilin Venture Capital China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ProovTest

Biotechnology
Fertility
Medical Device
$9M07 Dec 2021 Boulder, Colorado, United States

Prime Genomics

Biotechnology
Genetics
Health Care
$47K03 Dec 2021 Mountain View, California, United States

Zero Grocery

Consumer Goods
Delivery Service
Grocery
Waste Management
29 Nov 2021 Berkeley, California, United States

Rosy

Health Care
Mobile Apps
Sex Tech
Wellness
Women's
$2M15 Nov 2021 Dallas, Texas, United States

xCures

Artificial Intelligence
Biotechnology
Health Care
Machine Learning
Medical
Pharmaceutical
$125K06 Nov 2021 California, United States

Pause Well-Aging

Consumer Goods
$3M27 Oct 2021 New York, New York, United States

4D Healthware

Health Care
Medical
Software
$1M12 Oct 2021 Chicago, Illinois, United States

Nalu Bio

Biotechnology
21 Sep 2021 San Francisco, California, United States

Innovare

EdTech
Education
Social Entrepreneurship
Social Impact
Software
$3M16 Sep 2021 Chicago, Illinois, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Portfolia?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: